<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01235325</url>
  </required_header>
  <id_info>
    <org_study_id>HRB RP/2006/38</org_study_id>
    <nct_id>NCT01235325</nct_id>
  </id_info>
  <brief_title>The Effect of Vitamin K Supplementation on Bone Health in Adult Crohn's Disease Patients</brief_title>
  <official_title>The Effect of Vitamin K Supplementation on Bone Health Indices in Adult Crohn's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College Cork</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Health Research Board, Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University College Cork</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the impact of a 12 month vitamin K supplementation intervention on bone health in
      adult Crohn's disease patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To assess the impact of 12 months of vitamin K1 supplementation (plus vitamin D and calcium
      supplementation to avoid deficiency of these problematic nutrients) at a level which leads to
      dramatically (i.e greater than 70%) reduced levels of undercarboxylated osteocalcin - a
      functional marker of vitamin K status, on vitamin K status, the rate of bone formation and
      bone resorption, using biochemical markers of bone turnover, and bone mineral density in
      adult patients with longstanding Crohn's disease.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>% Undercarboxylated osteocalcin</measure>
    <time_frame>12 months</time_frame>
    <description>Measurement of carboxylated and undercarboxylated osteocalcin (expressed as %) as a senstive functional marker of vitamin K status.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>25-Hydroxy vitamin D (25OHD)</measure>
    <time_frame>12 months</time_frame>
    <description>Measurement of serum 25-Hydroxy vitamin D as status measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intact Parathyroid hormone (iPTH)</measure>
    <time_frame>12 months</time_frame>
    <description>Measurement of intact parathyroid hormone to determine hyperparathyroidism, hypercalcemia, vitamin D deficiency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary creatinine</measure>
    <time_frame>12 months</time_frame>
    <description>For standardisation of urinary NTx measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum phylloquinone</measure>
    <time_frame>12 months</time_frame>
    <description>Determination of serum phylloquinone by HPLC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical markers of bone turnover (BAP, CTx, NTx)</measure>
    <time_frame>12 months</time_frame>
    <description>Use of biochemical markers of bone turnover to assess the effect of supplementation on bone health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone mineral density (BMD)</measure>
    <time_frame>12 month</time_frame>
    <description>Measurement of bone mineral density (BMD) by iDEXA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Food Frequency Questionnaire (FFQ) for habitual vitamin K, vitamin D and calcium intakes</measure>
    <time_frame>cross-sectional (baseline only)</time_frame>
    <description>Food frequency questionnaire (FFQ) to estimate habitual vitamin K (vitamin D and calcium) status, cross-sectionally at baseline.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Supplementation</condition>
  <condition>Bone Health</condition>
  <condition>Crohn's Disease</condition>
  <arm_group>
    <arm_group_label>Placebo oil capsule</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Banner Pharmacaps Europe</description>
  </arm_group>
  <arm_group>
    <arm_group_label>phylloquinone (1000 mcg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Banner Pharmacaps Europe</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>phylloquinone (vitamin K1)</intervention_name>
    <description>1000 mcg phylloquinone (vitamin K1) once daily for 12 months</description>
    <arm_group_label>phylloquinone (1000 mcg)</arm_group_label>
    <other_name>Banner Pharmacaps Europe</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo oil capsule</description>
    <arm_group_label>Placebo oil capsule</arm_group_label>
    <other_name>Banner Pharmacaps Europe</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  long-standing Crohn's disease - disease diagnosis &gt; 5 years

          -  in clinical remission at baseline - Harvey-Bradshaw score (&lt; 5)

          -  aged between 18-70 years

        Exclusion Criteria:

          -  use of steroid medications to treat disease or flare up

          -  use of blood thinning medications (warfarin, heparin, asprin, dicoumarol derivatives)
             which may influence vitamin K metabolism

          -  use of bisphosphonates, calcitonin medications (to treat osteoporosis)

          -  use of experimental drugs (in the last 30 days) or inclusion in another intervention
             trial

          -  bone mineral density &lt; -2.5 (indicative of osteoporosis) or previous diagnosis of
             osteoporosis

          -  use of vitamin/mineral/fish liver oil dietary supplements

          -  use of other alternative supplements (i.e herbal)

          -  if the patient is under 18 or over 70 years of age

          -  presence of a significant acute or chronic coexisting illness (cardiovascular,
             immunological or a condition which in the investigator's judgement, contraindicates
             involvement in the study)

          -  presence of malignant or any concomitant end-stage organ disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin D Cashman, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University College Cork, Ireland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fergus Shanahan, Professor</last_name>
    <role>Study Director</role>
    <affiliation>University College Cork, Ireland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Investigations Unit, Cork University Hospital, Wilton</name>
      <address>
        <city>Cork</city>
        <state>Co. Cork</state>
        <zip>00000</zip>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2010</study_first_submitted>
  <study_first_submitted_qc>November 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2010</study_first_posted>
  <last_update_submitted>November 5, 2010</last_update_submitted>
  <last_update_submitted_qc>November 5, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Professor Kevin D. Cashman</name_title>
    <organization>University College Cork, Ireland</organization>
  </responsible_party>
  <keyword>vitamin K</keyword>
  <keyword>supplementation</keyword>
  <keyword>bone health indices</keyword>
  <keyword>adult</keyword>
  <keyword>Crohn's disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin K</mesh_term>
    <mesh_term>Vitamin K 1</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

